Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Portfolio Pulse from Lisa Levin
Several stocks experienced significant price movements in Friday's mid-day session. Novonix Limited's shares rose by 27.4% after the company announced it achieved high-performance battery grade synthetic graphite production milestones. Iovance Biotherapeutics' shares jumped 20.8% after the FDA extended its BLA Priority Review for lifileucel. Faraday Future Intelligent Electric's shares gained 19.5% after announcing a new car delivery. On the other hand, Avalo Therapeutics' shares fell 31.6% after agreeing to divest AVTX-800 series. PTC Therapeutics' shares fell 31.6% after receiving a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna.
September 15, 2023 | 4:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Avalo Therapeutics' shares fell 31.6% after agreeing to divest AVTX-800 series.
The company's decision to divest AVTX-800 series is a negative development, which likely led to the decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
PTC Therapeutics' shares fell 31.6% after receiving a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna.
The negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna is a negative development for the company, which likely led to the decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Faraday Future Intelligent Electric's shares gained 19.5% after announcing a new car delivery.
The announcement of a new car delivery is a positive development for the company, which likely led to the increase in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Iovance Biotherapeutics' shares jumped 20.8% after the FDA extended its BLA Priority Review for lifileucel.
The FDA's extension of the BLA Priority Review for lifileucel is a positive development for the company, which likely led to the increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Novonix's shares rose by 27.4% after the company announced it achieved high-performance battery grade synthetic graphite production milestones.
The company's achievement of production milestones is a positive development, which likely led to the increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100